“…The first in vivo reports of H 4 receptor activity involved neutrophilia models induced by the TLR ligand zymosan where H 4 receptor antagonists were shown to be anti-inflammatory (Gantner et al, 2002;Thurmond et al, 2004). Effects on neutrophils can also be seen in a rat colitis model where treatment with H 4 receptor antagonists reduced tissue damage, neutrophilia, and tissue TNFa levels (Fogel et al, 2005;Varga et al, 2005). Treatment with JNJ-7777120 was protective in a model of gastric ulceration .…”